U.S. pharma huge copyright scrapped two experimental weight loss drugs final yr—a after-everyday tablet, lotiglipron, as a result of elevated liver enzymes along with a two times-everyday capsule, danuglipron, as a result of solid Unwanted side effects—but CEO Albert Bourla has claimed the company is decided to “Participate in and get” in t